Eckert & Ziegler Strahlen- und Medizintechnik AG Logo

Eckert & Ziegler Strahlen- und Medizintechnik AG

ISIN

DE0005659700

Ticker

EUZ

Sector

Health Care

Sub-Industry

Biotechnology

Country

Germany

Year Founded

1997

About Eckert & Ziegler Strahlen- und Medizintechnik AG

Company Description

The Eckert & Ziegler Group is one of the world's largest providers of isotope technology for medical, scientific and industrial use. The core businesses of the Group are cancer therapy, industrial radiometry and nuclear-medical imaging. The two business segments are: Medical and Isotope Products.
Eckert & Ziegler was founded in 1997 as a holding company.

Headcount

828

Served Area

Worldwide

Headquarters

Robert-Rössle-Straße 10
13125, Berlin
Germany

Filings & Publications

  • Consolidated Report 2021 - Q1 English πŸ‡¬πŸ‡§
  • Consolidated Report 2021 - Q1 German πŸ‡©πŸ‡ͺ
  • Consolidated Report 2021 - Q2 German πŸ‡©πŸ‡ͺ
  • Consolidated Report 2021 - Q2 English πŸ‡¬πŸ‡§
  • Consolidated Report 2021 - Q3 German πŸ‡©πŸ‡ͺ
  • Consolidated Report 2021 - Q3 English πŸ‡¬πŸ‡§
  • Consolidated Report 2021 - Q4 German πŸ‡©πŸ‡ͺ
  • Consolidated Report 2021 - Q4 English πŸ‡¬πŸ‡§
  • Consolidated Report 2020 - Q1 German πŸ‡©πŸ‡ͺ
  • Consolidated Report 2020 - Q1 English πŸ‡¬πŸ‡§
  • Consolidated Report 2020 - Q2 English πŸ‡¬πŸ‡§
  • Consolidated Report 2020 - Q2 German πŸ‡©πŸ‡ͺ
  • Consolidated Report 2020 - Q3 German πŸ‡©πŸ‡ͺ
  • Consolidated Report 2020 - Q3 English πŸ‡¬πŸ‡§
  • Consolidated Report 2020 - Q4 English πŸ‡¬πŸ‡§
  • Consolidated Report 2019 - Q1 German πŸ‡©πŸ‡ͺ
  • Consolidated Report 2019 - Q1 English πŸ‡¬πŸ‡§
  • Consolidated Report 2019 - Q2 German πŸ‡©πŸ‡ͺ
  • Consolidated Report 2019 - Q2 English πŸ‡¬πŸ‡§
  • Consolidated Report 2019 - Q3 German πŸ‡©πŸ‡ͺ
  • Consolidated Report 2019 - Q3 English πŸ‡¬πŸ‡§
  • Consolidated Report 2019 - Q4 English πŸ‡¬πŸ‡§
  • Consolidated Report 2019 - Q4 German πŸ‡©πŸ‡ͺ
  • Consolidated Report 2018 - Q2 German πŸ‡©πŸ‡ͺ
  • Consolidated Report 2018 - Q2 English πŸ‡¬πŸ‡§
  • Consolidated Report 2018 - Q3 German πŸ‡©πŸ‡ͺ
  • Consolidated Report 2018 - Q3 English πŸ‡¬πŸ‡§
  • Consolidated Report 2018 - Q4 English πŸ‡¬πŸ‡§
  • Consolidated Report 2018 - Q4 German πŸ‡©πŸ‡ͺ
  • Consolidated Report 2022 - Q1 German πŸ‡©πŸ‡ͺ
  • Consolidated Report 2022 - Q1 English πŸ‡¬πŸ‡§
  • Consolidated Report 2022 - Q2 English πŸ‡¬πŸ‡§
  • Consolidated Report 2022 - Q3 English πŸ‡¬πŸ‡§
  • Consolidated Report 2017 - Q2 English πŸ‡¬πŸ‡§
  • Consolidated Report 2017 - Q2 German πŸ‡©πŸ‡ͺ
  • Consolidated Report 2016 - Q2 English πŸ‡¬πŸ‡§
  • Consolidated Report 2016 - Q2 German πŸ‡©πŸ‡ͺ
  • Consolidated Report 2014 - Q2 English πŸ‡¬πŸ‡§
  • Consolidated Report 2014 - Q2 German πŸ‡©πŸ‡ͺ

Insider Trades

Date Trading entity / Person Association Trade type Volume
30.08.2023 Eckert, Dr. Andreas Supervisory board Sell EUR 1,526,400.00
30.08.2023 Eckert Wagniskapital und FrΓΌhphasenfinanzierung GmbH Close relation Buy EUR 1,526,400.00
11.08.2023 Perschmann, Frank Supervisory board Buy EUR 16,600.00
13.01.2023 NEON Equity AG Close relation Buy EUR 2,115.00
12.01.2023 Blunck, Dr. Thomas Board Sell EUR 57,402.00
12.01.2023 Blunck, Dr. Thomas Board Sell EUR 32,160.00
11.01.2023 Bouterfa, Dr. Hakim Board Buy EUR 124,800.00
21.12.2022 Eckert Wagniskapital und FrΓΌhphasenfinanzierung GmbH Close relation Buy EUR 1,432,800.00
06.12.2022 Maennig, Prof. Dr. Wolfgang Supervisory board Buy EUR 72,745.31
05.12.2022 Carpio GmbH Close relation Buy EUR 73,826.53

Capital Markets Information

ISIN

DE0005659700

LEI

391200EUDABLUKXCKG48

Sector

Health Care

Industry Group

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Sub-Industry

Biotechnology

Designated Sponsor

DZ Bank AG Deutsche Zentral-Genossenschaftsbank

Listed Stock Exchange

Frankfurt Stock Exchange

Stock Index

SDAX

TecDAX

Contact Investor Relations Department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.